Welcome to Medications.com

CV Therapeutics Reports 2007 Third Quarter Financial Results - PharmaLive.com (press release)

... Ranexa sales and marketing expenses and lower ACEON(R) sales and marketing expenses associated with the end of the ACEON(R) co-promotion arrangement. ...

http://www.pharmalive.com/News/in... | Posted: Wed Nov 07 07:53:52 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea